Ratings Target Healthcare REIT PLC

Equities

THRL

GB00BJGTLF51

Market Closed - London S.E. 11:35:10 2024-05-31 am EDT 5-day change 1st Jan Change
78.2 GBX -0.89% Intraday chart for Target Healthcare REIT PLC +0.64% -9.39%

Summary

  • According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Its low valuation, with P/E ratio at 7.44 and 7.18 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • Based on current prices, the company has particularly high valuation levels.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Residential REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
-9.39% 617M
D+
+2.92% 27.36B
A-
+6.33% 24.64B
B
+1.99% 21.31B
B-
+4.78% 16.68B
B+
-0.56% 15.62B
B
-11.72% 14.71B
C
+0.86% 12.72B
B
-11.02% 11.71B
B-
+3.38% 10.94B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. THRL Stock
  4. Ratings Target Healthcare REIT PLC